Core Insights - Dermata Therapeutics will present at the Life Sciences Virtual Investor Forum on September 18, 2025, led by CEO Gerry Proehl [1][9] - The event will allow real-time interaction between investors and the company, with archived webcasts available for those unable to attend live [2][10] Company Highlights - Dermata has announced a strategic pivot towards over-the-counter (OTC) skin care treatments to meet the increasing demand for high-quality, scientifically validated products [7][14] - The company plans to launch a once-weekly OTC acne kit in mid-2026, which is expected to be significantly differentiated from existing acne treatments [7][14] Event Details - The presentation is scheduled for September 18 at 11:30 AM EST, with opportunities for one-on-one meetings available from September 16-26 [2][10] - Investors are encouraged to pre-register and conduct system checks to facilitate participation [3][11] About Virtual Investor Conferences - Virtual Investor Conferences (VIC) is a leading platform for publicly traded companies to engage directly with investors [4][12] - VIC provides enhanced capabilities for companies to connect with investors, schedule meetings, and present dynamic content [5][13]